Bionano Genomics, Inc. (BNGO) vs Retractable Technologies, Inc. (RVP)

Bionano Genomics, Inc. and Retractable Technologies, Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. and Retractable Technologies, Inc. are of similar size ($20.5M and $19.9M). Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −11.2%. Retractable Technologies, Inc. has the higher net margin (−10.6% vs −106.6%) and the higher return on invested capital (−42.1% vs −81.7%). Across the 18 metrics below, Retractable Technologies, Inc. leads on 13 and Bionano Genomics, Inc. on 5.

Valuation

Metric BNGO RVP Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 0.64 0.62 2.83
P/B 0.61 0.29 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 1.22 16.08
EV/Sales 0.49 (0.54) 3.06
Earnings yield (180.84%) (17.14%) (1.84%)
Free cash flow yield (106.75%) (24.37%) 0.17%

Profitability

Metric BNGO RVP Medical Instruments & Supplies median
Gross margin 47.51% (1.45%) 54.62%
Operating margin (106.67%) (66.90%) 1.64%
Net margin (106.58%) (10.62%) 0.00%
Free cash flow margin (67.87%) (15.07%) 1.61%
Return on equity (83.56%) (4.84%) 0.00%
Return on assets (52.04%) (2.49%) 0.00%
Return on invested capital (81.68%) (42.05%) 0.00%

Growth

Metric BNGO RVP Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% (11.16%) 9.20%
EPS growth (last fiscal year) 94.50% (7.50%) —
Revenue growth, 5-year CAGR 27.37% (14.11%) 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO RVP Medical Instruments & Supplies median
Debt to equity 0.11 0.01 0.08
Current ratio 2.48 4.93 2.49
Net debt to EBITDA 1.06 2.69 0.83

Dividend

Metric BNGO RVP Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric BNGO RVP Medical Instruments & Supplies median
Market cap 19.90m 20.45m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack